Home › Companies › ANI PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ANI PHARMACEUTICALS INC.’s Form 8-K, filed May 23, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 21, 2024: 11 items on ANI PHARMACEUTICALS INC.’s Form 8-K, filed May 23, 2024: 8 elected · 3 passed (calculated).
Notable dissent: 1 director (12.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ANI PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ANI PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Thomas Haughey | 14,837,619 | 2,060,363 | 15,911 | -- | 1,192,463 | 88% | Elected | — |
| Elect Director: Nikhil Lalwani | 16,838,898 | 68,125 | 6,870 | -- | 1,192,463 | 99.6% | Elected | — |
| Elect Director: Matthew J. Leonard, R.Ph. | 16,286,549 | 615,181 | 12,163 | -- | 1,192,463 | 96% | Elected | — |
| Elect Director: Antonio R. Pera | 16,451,771 | 447,404 | 14,718 | -- | 1,192,463 | 97% | Elected | — |
| Elect Director: Muthusamy Shanmugam | 16,785,294 | 116,444 | 12,155 | -- | 1,192,463 | 99.3% | Elected | — |
| Elect Director: Renee P. Tannenbaum, Pharm.D. | 15,830,187 | 1,068,993 | 14,713 | -- | 1,192,463 | 94% | Elected | — |
| Elect Director: Jeanne A. Thoma | 16,487,783 | 411,401 | 14,709 | -- | 1,192,463 | 98% | Elected | — |
| Elect Director: Patrick D. Walsh | 16,477,655 | 424,150 | 12,088 | -- | 1,192,463 | 97% | Elected | — |
| 2. Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending Decemb | 18,043,078 | 56,735 | 6,543 | -- | -- | 99.7% | Passed (calculated) | — |
| 3. Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis | 16,139,473 | 762,718 | 11,702 | -- | 1,192,463 | 95% | Passed (calculated) | — |
| 4. Approval o f the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan | 16,031,866 | 871,204 | 10,823 | -- | 1,192,463 | 95% | Passed (calculated) | — |
Source: ANI PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 23, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
250 asset managers disclosed a vote on at least one ANI PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Antonio R. Pera
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Antonio R. Pera”): 16,451,771 for, 447,404 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,501,186 for, 48 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,893 | 48 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeanne A. Thoma
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeanne A. Thoma”): 16,487,783 for, 411,401 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,501,186 for, 48 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,893 | 48 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Matthew J. Leonard, R.Ph.
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Matthew J. Leonard, R.Ph.”): 16,286,549 for, 615,181 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,168,458 for, 332,776 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,941 | 0 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 138,860 | 0 | 0 | Against |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 11,699 | 55,518 | 0 | 0 | Mixed |
| Brighthouse | 24,882 | 36,524 | 0 | 0 | Mixed |
| Loomis Sayles | 0 | 47,156 | 0 | 0 | Against |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,924 | 15,330 | 0 | 0 | Mixed |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Muthusamy Shanmugam
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Muthusamy Shanmugam”): 16,785,294 for, 116,444 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,501,186 for, 48 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,893 | 48 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Nikhil Lalwani
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nikhil Lalwani”): 16,838,898 for, 68,125 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,501,186 for, 48 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,893 | 48 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Patrick D. Walsh
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick D. Walsh”): 16,477,655 for, 424,150 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,482,013 for, 19,221 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,893 | 48 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 55,518 | 11,699 | 0 | 0 | Mixed |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Renee P. Tannenbaum, Pharm.D.
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 15,830,187 for, 1,068,993 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,165,293 for, 335,941 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,863 | 78 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 138,860 | 0 | 0 | Against |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 11,699 | 55,518 | 0 | 0 | Mixed |
| Brighthouse | 24,882 | 36,524 | 0 | 0 | Mixed |
| Loomis Sayles | 0 | 47,156 | 0 | 0 | Against |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,924 | 15,330 | 0 | 0 | Mixed |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Thomas Haughey
ANI PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Thomas Haughey”): 14,837,619 for, 2,060,363 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, (i) the eight directors were elected, (ii) the appointment of the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, (iii) the compensation of the Company's named executive officers, on an advisory basis, was app…”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 5,558,885 for, 942,349 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 22,825 | 252,116 | 0 | 0 | Mixed |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 217,101 | 0 | 0 | Against |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 138,860 | 0 | 0 | Against |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 0 | 92,181 | 0 | 0 | Against |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 0 | 67,217 | 0 | 0 | Against |
| Brighthouse | 24,882 | 36,524 | 0 | 0 | Mixed |
| Loomis Sayles | 0 | 47,156 | 0 | 0 | Against |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,924 | 15,330 | 0 | 0 | Mixed |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To approve the Amended and Restated 2022 Stock Incentive Plan.
ANI PHARMACEUTICALS INC.’s own tally for this item (“4. Approval o f the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan”): 16,031,866 for, 871,204 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 6,397,413 for, 125,081 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,918 | 23 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 7,100 | 65,509 | 0 | 0 | Mixed |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 0 | 41,604 | 0 | 0 | Against |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 13 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To approve the compensation of the Company's named executive officers, on an advisory basis;
ANI PHARMACEUTICALS INC.’s own tally for this item (“3. Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis”): 16,139,473 for, 762,718 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,941 | 0 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 0 | 41,604 | 0 | 0 | Against |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 5,884 | 32,622 | 0 | 0 | Mixed |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Fund voting reports, all 87 managers: 6,389,582 for, 111,214 against, 1,630 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 925,196 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 769,899 | 0 | 0 | 0 | For |
| BlackRock | 601,985 | 0 | 0 | 0 | For |
| State Street | 534,476 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 364,095 | 0 | 0 | 0 | For |
| Ranger Investment Management, L.P. | 348,033 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 339,078 | 0 | 0 | 0 | For |
| Global Alpha Capital Management Ltd. | 0 | 288,485 | 0 | 0 | Against |
| Nuveen | 231,446 | 0 | 0 | 0 | For |
| Invesco | 225,244 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 214,517 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 198,233 | 0 | 0 | 0 | For |
| Charles Schwab | 196,339 | 0 | 0 | 0 | For |
| JPMorgan | 170,596 | 0 | 0 | 0 | For |
| Northern Trust | 147,074 | 12 | 0 | 0 | For |
| THOMPSON SIEGEL & WALMSLEY LLC | 146,798 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 132,375 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 118,791 | 0 | 0 | Against |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 106,903 | 0 | 0 | 0 | For |
| SEI | 92,596 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 87,487 | 0 | 0 | 0 | For |
| Hillsdale Investment Management Inc. | 75,310 | 0 | 0 | 0 | For |
| Dimensional | 74,927 | 0 | 0 | 0 | For |
| Renaissance | 67,731 | 0 | 0 | 0 | For |
| Citadel | 66,878 | 0 | 0 | 0 | For |
Institutional-manager reports, all 185 managers: 6,955,017 for, 710,397 against, 4,329 abstained, 200 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024;
ANI PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accountin”): 18,043,078 for, 56,735 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 6,501,211 for, 23 against, 1,630 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,774,774 | 0 | 0 | 0 | For |
| Vanguard | 1,270,364 | 0 | 0 | 0 | For |
| Dimensional | 507,771 | 0 | 0 | 0 | For |
| Fidelity | 326,407 | 0 | 0 | 0 | For |
| State Street | 274,918 | 23 | 0 | 0 | For |
| TIAA | 230,708 | 0 | 0 | 0 | For |
| Invesco | 221,130 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 217,101 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 194,910 | 0 | 0 | 0 | For |
| Charles Schwab | 190,219 | 0 | 0 | 0 | For |
| Waddell & Reed | 138,860 | 0 | 0 | 0 | For |
| JPMorgan | 114,817 | 0 | 0 | 0 | For |
| SEI | 92,181 | 0 | 0 | 0 | For |
| World Funds Trust | 72,609 | 0 | 0 | 0 | For |
| Russell Investments | 69,867 | 0 | 0 | 0 | For |
| Empower | 67,217 | 0 | 0 | 0 | For |
| Brighthouse | 61,406 | 0 | 0 | 0 | For |
| Loomis Sayles | 47,156 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 43,500 | 0 | 0 | 0 | For |
| American Century | 41,604 | 0 | 0 | 0 | For |
| Equitable | 39,052 | 0 | 0 | 0 | For |
| Jackson National | 38,506 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,272 | 0 | 0 | 0 | For |
| Prudential/PGIM | 31,254 | 0 | 0 | 0 | For |
| Transamerica | 30,121 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 21,108,152 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 8.41% |
| 2 | Vanguard | 6.02% |
| 3 | Dimensional | 2.41% |
| 4 | Fidelity | 1.55% |
| 5 | State Street | 1.30% |
| 6 | TIAA | 1.09% |
| 7 | Invesco | 1.05% |
| 8 | Columbia Threadneedle | 1.03% |
| 9 | WILLIAM BLAIR FUNDS | 0.92% |
| 10 | Charles Schwab | 0.90% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Rubric Capital Management LP | 4.38% |
| 2 | Deep Track Capital, LP | 3.65% |
| 3 | BlackRock | 2.85% |
| 4 | State Street | 2.53% |
| 5 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.72% |
| 6 | Ranger Investment Management, L.P. | 1.65% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.61% |
| 8 | Global Alpha Capital Management Ltd. | 1.37% |
| 9 | Nuveen | 1.10% |
| 10 | Invesco | 1.07% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 2,548,892 | 12.08% | Form 13F, quarter ended March 31, 2024 |
| Meridian Venture Partners II, L.P. | 1,419,381 | 6.72% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Robert E. Brown, Jr. | 1,419,381 | 6.72% | Schedule 13D, filed March 14, 2024 |
| Vanguard Group | 1,277,470 | 6.05% | Form 13F, quarter ended March 31, 2024 |
| Rubric Capital Management LP | 1,125,000 | 5.33% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Muthusamy Shanmugam | 896,010 | 4.24% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Dimensional Fund Advisors | 609,173 | 2.89% | Form 13F, quarter ended March 31, 2024 |
| State Street | 574,838 | 2.72% | Form 13F, quarter ended March 31, 2024 |
| Nikhil Lalwani | 476,059 | 2.26% | Proxy statement (DEF 14A), proxy filed April 5, 2024 |
| Goldman Sachs | 379,026 | 1.80% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 21,108,152 shares outstanding, as reported by ANI PHARMACEUTICALS INC. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ANI PHARMACEUTICALS INC.'s shareholder meeting held May 21, 2024, in the 2023-2024 proxy season, 250 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 3,304 separate fund positions. On the most widely held item on that ballot — To approve the compensation of the Company's named executive officers, on an advisory basis; — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANI PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANI PHARMACEUTICALS INC.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ANI PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “ANI PHARMACEUTICALS (ANIP) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ani-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.